2013 American Transplant Congress
Cumulative Effect of Metabolic Syndrome Components in Predicting Major Adverse Cardiovascular Events after Kidney Transplantation
Background: Metabolic syndrome (MS) refers to a clustering of factors that increases cardiovascular risk. The WHO 1999 definition of MS includes the presence of any…2013 American Transplant Congress
Assessing Cell Mediated Immunity (CMI) Status by the ImmuKnow Assay in Renal Transplant Recipients
BACKGROUND: Transplant recipients have a high risk of infection due to overimmunosuppression. However, underimmunosuppression carries with it the risk of rejection. It would be necessary…2013 American Transplant Congress
Comparative Ability of Different Metabolic Syndrome Definitions To Predict Major Adverse Cardiovascular Events after Kidney Transplantation
Background: Metabolic syndrome (MS) refers to a clustering of factors that increases cardiovascular risk. There are at least 4 definitions of MS: International Diabetes Federation…2013 American Transplant Congress
Novel Monitoring Panel for Tolerance-Inducing Effects of Extracorporal Photopheresis
Goal: Extracorporal photopheresis (ECP) has been used as a therapeutic option for acute and chronic rejection after transplantation. Tolerance-inducing effects of ECP after transplantation are…2013 American Transplant Congress
Alemtuzumab for Induction Therapy for Small Bowel Transplantation
IntroductionSmall bowel transplantation can be performed for short bowel syndrome. The ideal immunosuppressive regimen after small bowel transplantation still needs to be defined. Here we…2013 American Transplant Congress
Health-Related Quality of Life in the Pre-Transplant Candidate Low MELD for End-Stage Liver Disease (MELD) Score: A Pilot Study
Transplant Surgery, Northwestern Memorial Hospital, Chicago, IL
Cadaveric liver organ allocation is based on the model for end-stage liver disease (MELD) score. Those with low MELD scores (≤ 15) are considered to…2013 American Transplant Congress
Critical Analysis of Valganciclovir Dosing and Renal Function on the Development of CMV Infection in Kidney Transplantation
Purpose: To evaluate factors that impact the development of CMV infection in renal transplant recipients.Background: Cytomegalovirus (CMV) infection is one of the most common and…2013 American Transplant Congress
Impact of Donor-Specific Anti-HLA and Anti-Angiotensin-II Type 1 Receptor Antibodies on Graft Fibrosis after Immunosuppression Withdrawal in Pediatric Liver Transplantation
Pediatric living-donor liver transplant (LDLT) recipients can often exhibit a reduction or cessation of immunosuppression (IS); over the long term, a high incidence of progressive…2013 American Transplant Congress
What Is the Best Treatment for BK Viremia after Kidney Transplantation: Results of a 5-Year Screening Study
Purpose: Various anecdotal reports have described clinical activity of cidofovir, leflunomide, and ciprofloxacin in clearing the BK virus. Our aim was to define the factors…2013 American Transplant Congress
Clinical Outcomes in Sensitized Heart Transplant Patients Bridged with Left Ventricular Assist Devices
Center for Heart Transplant and Assist Device, Advocate Christ Medical Center, Oak Lawn, IL
Background: Patients with pre-transplant left ventricular assist devices (LVAD) develop circulating antibodies with potential donor reactivity after cardiac transplantion. The aim of this study was…
American Transplant Congress abstracts